FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

As pesticides and wildfires rise, kids with cancer need resources

2.

Taking vitamin D daily decreased cancer mortality, according to a study.

3.

Recurrent UTIs impact eGFR in children with vesicoureteral reflux

4.

In Resectable Lung Cancer, Perioperative Nivolumab Increases EFS.

5.

Underprescribed for Alcohol Use Disorder is pharmacotherapy.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot